185 related articles for article (PubMed ID: 15539807)
1. Liquid growth hormone: preservatives and buffers.
Kappelgaard AM; Bojesen A; Skydsgaard K; Sjögren I; Laursen T
Horm Res; 2004; 62 Suppl 3():98-103. PubMed ID: 15539807
[TBL] [Abstract][Full Text] [Related]
2. Pain perception after subcutaneous injections of media containing different buffers.
Laursen T; Hansen B; Fisker S
Basic Clin Pharmacol Toxicol; 2006 Feb; 98(2):218-21. PubMed ID: 16445598
[TBL] [Abstract][Full Text] [Related]
3. Norditropin SimpleXx: a liquid human growth hormone formulation, a pen system and an auto-insertion device.
Müller J; Skakkebaek NE; Jacobsen BB; Keller E; Heinrich U; Hartmann K; Hokken-Koelega AC; Delemarre van de Waal HA
Horm Res; 1999; 51 Suppl 3():109-12. PubMed ID: 10592453
[TBL] [Abstract][Full Text] [Related]
4. Long-acting forms of growth hormone-releasing hormone and growth hormone: effects in normal volunteers and adults with growth hormone deficiency.
Clemmons DR
Horm Res; 2007; 68 Suppl 5():178-81. PubMed ID: 18174751
[TBL] [Abstract][Full Text] [Related]
5. Subcutaneous Injection of Drugs: Literature Review of Factors Influencing Pain Sensation at the Injection Site.
Usach I; Martinez R; Festini T; Peris JE
Adv Ther; 2019 Nov; 36(11):2986-2996. PubMed ID: 31587143
[TBL] [Abstract][Full Text] [Related]
6. Acceptability of Liquid Human Growth Hormone (hGH) [Norditropin Simple Xx®] in Adults and Children with GH Deficiency and Children with Chronic Renal Disease.
Drent ML; Jakobsdottir S; van Wijk JAE; Oostdijk W; Wit JM
Clin Drug Investig; 2002 Sep; 22(9):633-638. PubMed ID: 29492857
[TBL] [Abstract][Full Text] [Related]
7. Optimizing growth hormone efficacy: an evidence-based analysis.
Lustig RH
Horm Res; 2004; 62 Suppl 3():93-7. PubMed ID: 15539806
[TBL] [Abstract][Full Text] [Related]
8. Human growth hormone: new delivery systems, alternative routes of administration, and their pharmacological relevance.
Cázares-Delgadillo J; Ganem-Rondero A; Kalia YN
Eur J Pharm Biopharm; 2011 Jun; 78(2):278-88. PubMed ID: 21296662
[TBL] [Abstract][Full Text] [Related]
9. [Relevance of nerve blocks in treating and diagnosing low back pain--is the quality decisive?].
Hildebrandt J
Schmerz; 2001 Dec; 15(6):474-83. PubMed ID: 11793154
[TBL] [Abstract][Full Text] [Related]
10. Long-term challenges in growth hormone treatment.
Leal Cerro A
Horm Res; 2004; 62 Suppl 4():23-30. PubMed ID: 15591763
[TBL] [Abstract][Full Text] [Related]
11. Development of a multidose formulation for a humanized monoclonal antibody using experimental design techniques.
Gupta S; Kaisheva E
AAPS PharmSci; 2003; 5(2):E8. PubMed ID: 12866935
[TBL] [Abstract][Full Text] [Related]
12. Stepping into adulthood: the transition period.
Shalet S
Horm Res; 2004; 62 Suppl 4():15-22. PubMed ID: 15591762
[TBL] [Abstract][Full Text] [Related]
13. Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement.
Schneider HJ; Oertel H; Murck H; Pollmächer T; Stalla GK; Steiger A
Psychoneuroendocrinology; 2005 Jan; 30(1):29-37. PubMed ID: 15358440
[TBL] [Abstract][Full Text] [Related]
14. Stability of cefuroxime in 1% and 5% buffered eye drops determined with HPLC method.
Kodym A; Wiśniewski A; Knioła D; Olejniczak M
Acta Pol Pharm; 2011; 68(4):555-64. PubMed ID: 21796938
[TBL] [Abstract][Full Text] [Related]
15. The clinical usefulness of liquid human growth hormone (hGH) (Norditropin SimpleXx in the treatment of GH deficiency.
Iyoda K; Moriwake T; Seino Y; Niimi H
Horm Res; 1999; 51 Suppl 3():113-5. PubMed ID: 10592454
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone and glucose homeostasis.
Jørgensen JO; Krag M; Jessen N; Nørrelund H; Vestergaard ET; Møller N; Christiansen JS
Horm Res; 2004; 62 Suppl 3():51-5. PubMed ID: 15539799
[TBL] [Abstract][Full Text] [Related]
17. Adult height in patients treated for isolated growth hormone deficiency: role of birth weight.
Di Cesare Merlone A; Bozzola E; Castelnovi C; Chiabotto P; Costante L; De Sanctis L; Tinelli C; Bozzola M
Horm Res; 2005; 63(2):102-6. PubMed ID: 15767761
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular effects of growth hormone treatment: potential risks and benefits.
Colao A
Horm Res; 2004; 62 Suppl 3():42-50. PubMed ID: 15539798
[TBL] [Abstract][Full Text] [Related]
19. Application of a capillary electrophoresis method for simultaneous determination of preservatives in pharmaceutical formulations.
Jaworska M; Szulińska Z; Wilk M
J Sep Sci; 2005 Feb; 28(2):137-43. PubMed ID: 15754820
[TBL] [Abstract][Full Text] [Related]
20. An open-label acceptability study of Norditropin SimpleXx--a new liquid growth hormone formulation.
Stanhope R; Buchanan C; Butler G; Costigan C; Dunger D; Greene S; Hoey H; Hughes I; Kelnar C; Kirk J; Komulainen J; Lowry M; Warner J
J Pediatr Endocrinol Metab; 2001 Jun; 14(6):735-40. PubMed ID: 11453523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
